EP4121007
Samsetningar af and-amýlóíð-beta-peptíð trefjuþráða-mótefni í háum styrkleika og aðferðir til notkunar á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.3.2021EP published:
2.7.2025EP application number:
21722538.2
EP translation filed:
8.9.2025Grant published:
15.10.2025EPO information:
European Patent Register
Max expiry date:
18.3.2041Expiry date:
18.3.2027Next due date:
31.3.2027
Title in English:
HIGH CONCENTRATION ANTI-AMYLOID BETA PEPTIDE PROTOFIBRIL ANTIBODY FORMULATIONS AND METHODS OF USE THEREOFLanguage of the patent:
English
Timeline
Today
19.3.2021EP application
2.7.2025EP Publication
8.9.2025Translation submitted
15.10.2025Registration published
18.3.2027Expires
Owner
Name:
Eisai R&D Management Co., Ltd.Address:
6-10 Koishikawa, 4-Chome Bunkyo-Ku, Tokyo 112-8088, JP
Inventor
Name:
YOSHIDA, NobuoAddress:
Tokyo 112--8088, JP
Name:
SAKURAMOTO, NaomiAddress:
Kakamigahara-shi, Gifu 501--6195, JP
Name:
SAKAGUCHI, TakahisaAddress:
Kakamigahara-shi, Gifu 501--6195, JP
Name:
KITO, HirokazuAddress:
Kakamigahara-shi, Gifu 501--6195, JP
Name:
OZAWA, TakahiroAddress:
Kakamigahara-shi, Gifu 501--6195, JP
Name:
JOSHI, AnjaliAddress:
Cary, North Carolina 27519, US
Name:
HSU, Yung YuehAddress:
Carlisle, Massachusetts 01741, US
Name:
SOUILLAC, PierreAddress:
Winchester, Massachusetts 01890, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
202062992746 PDate:
20.3.2020Country:
US
Number:
202063027263 PDate:
19.5.2020Country:
US
Classification
Categories:
A61K 9/00, A61K 39/00, A61K 47/12, A61K 47/18, A61K 47/26
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 20.3.2026
Expires: 18.3.2027
Payer: Árnason Faktor ehf.